{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:02:50Z","timestamp":1789779770105,"version":"4.0.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Ciencia","award":["CP18\/00116"],"award-info":[{"award-number":["CP18\/00116"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Serum levels of soluble urokinase-type plasminogen activator receptor (suPAR) are high in some patients with idiopathic nephrotic syndrome (INS). Given that suPAR constitutes a predictor of vascular disease and has been associated with endothelial dysfunction, we hypothesized that suPAR levels are related to endothelial activation or dysfunction in INS patients. The aims of this study were to evaluate the relationship between serum concentrations of endothelial biomarkers and suPAR in patients with different histological patterns of INS and healthy controls, and to determine the demographic, clinical and biochemical characteristics of INS patients that influence suPAR serum levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This observational, cross-sectional study included patients with INS, diagnosed with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS) or membranous nephropathy (MN) by renal biopsy. Patient demographic, clinical and biochemical characteristics were recorded and blood samples were obtained at the time of diagnosis. Measurements of suPAR and endothelial molecules via serum levels were performed using Enzyme-Linked ImmunoSorbent Assay kits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with nephrotic syndrome (n\u2009=\u2009152) caused by FSGS, MCD or MN had increased circulating levels of endothelial markers. suPAR levels positively correlated with age and the serum levels of almost all endothelial markers. Generally, endothelial cell molecules positively correlated with each other. suPAR levels were not associated with the histopathological pattern of INS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In patients with INS secondary to FSGS, MCD and NM, circulating levels of suPAR are independent of the primary renal disease, and significantly associated with age, glomerular filtration rate and the levels of various endothelial markers.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfz173","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T14:21:30Z","timestamp":1574086890000},"page":"543-549","source":"Crossref","is-referenced-by-count":12,"title":["Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome"],"prefix":"10.1093","volume":"14","author":[{"given":"Neus","family":"Roca","sequence":"first","affiliation":[{"name":"Servicio de Nefrolog\u00eda Pedi\u00e1trica, Consorci Hospitalari de Vic, Barcelona, Spain"},{"name":"Universitat de Vic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Jatem","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Universitario Arnau de Vilanova, Lleida, Spain"},{"name":"Vascular & Renal Translational Research Group, IRBLleida, Spanish Research Network for Renal Diseases (RedInRen.ISCIII), Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Mart\u00edn","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Universitario Arnau de Vilanova, Lleida, Spain"},{"name":"Vascular & Renal Translational Research Group, IRBLleida, Spanish Research Network for Renal Diseases (RedInRen.ISCIII), Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda Pedi\u00e1trica, Hospital Universitario de Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Molina","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Universitario Arnau de Vilanova, Lleida, Spain"},{"name":"Vascular & Renal Translational Research Group, IRBLleida, Spanish Research Network for Renal Diseases (RedInRen.ISCIII), Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Universitario Arnau de Vilanova, Lleida, Spain"},{"name":"Vascular & Renal Translational Research Group, IRBLleida, Spanish Research Network for Renal Diseases (RedInRen.ISCIII), Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons","family":"Segarra","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Universitario Arnau de Vilanova, Lleida, Spain"},{"name":"Vascular & Renal Translational Research Group, IRBLleida, Spanish Research Network for Renal Diseases (RedInRen.ISCIII), Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"2021021623483647800_sfz173-B1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"2021021623483647800_sfz173-B2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"2021021623483647800_sfz173-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2068691","article-title":"Soluble urokinase receptors in focal segmental glomerulosclerosis: a review on the scientific point of view","volume":"2016","author":"Kronbichler","year":"2016","journal-title":"J Immunol Res"},{"key":"2021021623483647800_sfz173-B4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/cei.12675","article-title":"Regulatory T cells and minimal change nephropathy: in the midst of a complex network","volume":"183","author":"Bertelli","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"2021021623483647800_sfz173-B5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","article-title":"The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis","volume":"85","author":"Meijers","year":"2014","journal-title":"Kidney Int"},{"key":"2021021623483647800_sfz173-B6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/ki.2014.346","article-title":"A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease","volume":"87","author":"Spinale","year":"2015","journal-title":"Kidney Int"},{"key":"2021021623483647800_sfz173-B7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ki.2013.513","article-title":"Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease","volume":"85","author":"Maas","year":"2014","journal-title":"Kidney Int"},{"key":"2021021623483647800_sfz173-B8","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1161\/STROKEAHA.112.664094","article-title":"Soluble urokinase plasminogen activator receptor is associated with inflammation in the vulnerable human atherosclerotic plaque","volume":"43","author":"Edsfeldt","year":"2012","journal-title":"Stroke"},{"key":"2021021623483647800_sfz173-B9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0971-9784.179588","article-title":"Soluble urokinase plasminogen activation receptor\u2013An emerging new biomarker of cardiovascular disease and critical illness","volume":"19","author":"Cyrille","year":"2016","journal-title":"Ann Card Anaesth"},{"key":"2021021623483647800_sfz173-B10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2011.01.049","article-title":"Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events","volume":"216","author":"Sehestedt","year":"2011","journal-title":"Atherosclerosis"},{"key":"2021021623483647800_sfz173-B11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2014.12.025","article-title":"Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease","volume":"239","author":"Mekonnen","year":"2015","journal-title":"Atherosclerosis"},{"key":"2021021623483647800_sfz173-B12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ijcard.2012.03.040","article-title":"CRP and suPAR are differently related to anthropometry and subclinical organ damage","volume":"167","author":"Lyngb\u00e6k","year":"2013","journal-title":"Int J Cardiol"},{"key":"2021021623483647800_sfz173-B13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1440-1797.2012.01575.x","article-title":"Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis","volume":"17","author":"Zhang","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"2021021623483647800_sfz173-B14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.atherosclerosis.2014.01.055","article-title":"Endothelial dysfuntion in children with idiopathic nephrotic syndrome","volume":"233","author":"Sharma","year":"2014","journal-title":"Atherosclerosis"},{"key":"2021021623483647800_sfz173-B15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D\u2019Agati","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2021021623483647800_sfz173-B16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000110088","article-title":"Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome","volume":"28","author":"Tkaczyk","year":"2008","journal-title":"Am J Nephrol"},{"key":"2021021623483647800_sfz173-B17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00001721-200210000-00006","article-title":"Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome","volume":"13","author":"Malyszko","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2021021623483647800_sfz173-B18","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1182\/blood-2010-10-315473","article-title":"Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis","volume":"117","author":"Smith","year":"2011","journal-title":"Blood"},{"key":"2021021623483647800_sfz173-B19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"2021021623483647800_sfz173-B20","first-page":"53","article-title":"Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis","volume":"34","author":"Segarra","year":"2014","journal-title":"Nefrologia"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/2\/543\/36283893\/sfz173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/2\/543\/36283893\/sfz173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T12:36:13Z","timestamp":1613738173000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/14\/2\/543\/5709132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,1,17]]},"published-print":{"date-parts":[[2021,2,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfz173","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,1,17]]}}}